Effects of Satureja Khuzestanica Jamzad on type 2 diabetes

Phase 2

Recruiting

• Conditions: type2 diabetes.; Diabetes mellitus due to underlying condition

• Registration Number: IRCT20191106045348N1
• Lead Sponsor: Khoram-Abad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 78

Inclusion Criteria

Age between 20 and 65 years
Age between 20 and 65 years
Willingness to cooperate
Completing the informed consent form

Exclusion Criteria

Insulin injection
Pregnant and lactating women
Weight loss diet
Inflammatory disease
Taking corticosteroids
Omega 3 consumption
Women who are planning to become pregnant
Allergy to safflower

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
CRP. Timepoint: Before and 12 weeks after beginning intervention. Method of measurement: Serum levels Measuring.;CAT. Timepoint: Before and 12 weeks after beginning intervention. Method of measurement: Serum levels Measuring.;SOD. Timepoint: Before and 12 weeks after beginning intervention. Method of measurement: Serum levels Measuring.;GPX. Timepoint: Before and 12 weeks after beginning intervention. Method of measurement: Serum levels Measuring.;TAC. Timepoint: Before and 12 weeks after beginning intervention. Method of measurement: Serum levels Measuring.;GR. Timepoint: Before and 12 weeks after beginning intervention. Method of measurement: Serum levels Measuring.;IL-6. Timepoint: Before and 12 weeks after beginning intervention. Method of measurement: Serum levels Measuring.